Subscribe To
Ultragenyx to host conference call for second quarter 2023 financial results and corporate update
NOVATO, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developme...
July 27, 2023, 9:00 pm
Btc20 presale hits soft cap with novel ‘buy bitcoin at $1’ concept
The BTC20 presale is ongoing, maintaining a steady price of $1. The funds raised have already exceeded $3.4 million, and an additional $3.05 million t...
July 27, 2023, 7:29 pm
Ultragenyx to host conference call for second quarter 2023 financial results and corporate update
NOVATO, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
July 27, 2023, 5:00 pm
Helius medical technologies, inc. expands stroke trial at the medical university of south carolina
— Number of subjects increased from 12 to 60 —— Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve non-invasive...
July 27, 2023, 11:05 am
3 millionaire-maker metaverse stocks to buy before the window closes
The rapid pace of the digital world is paving the way for novel investment opportunities, with the meta...
July 26, 2023, 3:09 pm
Monte rosa therapeutics appoints dr. anthony m. manning to board of directors
BOSTON, July 26, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing ...
July 26, 2023, 11:30 am
Boxx: earn treasury bill-like returns from option spreads
The Alpha Architect 1-3 Month Box ETF allows retail investors to earn Treasury Bill-like returns from the options market by buying 'box spreads'. The ...
July 25, 2023, 11:20 pm
Benitec biopharma announces 1-for-17 reverse stock split effective july 26, 2023
HAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene the...
July 25, 2023, 5:00 pm
Here’s a bitcoin etf you can buy right now
It’s offered by a Canadian firm that’s a proving ground for crypto funds and other novelties. U.S. citizens can sometimes get in. Read Full Story ...
July 25, 2023, 3:59 pm
3 autonomous driving stocks you better be buying on each and every dip
2023 has brought to us an equities market rebound and novel improvements upon language-based artificial...
July 25, 2023, 4:07 am
Kodiak sciences discontinues development of eye disorder therapeutic; shares plummet
Kodiak Sciences shares fell by more than 45% after the biopharmaceutical company announced that it was discontinuing its tarcocimab program for eye di...
July 24, 2023, 1:59 pm
Opthea to present at the 2023 ophthalmology innovation summit
MELBOURNE, Australia, July 24, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing ...
July 24, 2023, 6:00 am
The 3 most undervalued ai stocks to buy now: july 2023
Artificial intelligence is one of our most disruptive and transformative technologies. The creation of intelligent chatbots, such as OpenAI's ChatGP...
July 24, 2023, 4:54 am
Can this new $1 crypto be the next bitcoin on the ethereum blockchain?
Priced at $1, the BTC20 has already raised $1.3 million with its novel concept of being the ‘next Bit...
July 23, 2023, 5:44 pm
Axsome therapeutics: 'buy' the auvelity launch (rating upgrade)
Axsome Therapeutics' novel treatments for central nervous system disorders gain traction, with promisin...
July 23, 2023, 6:09 am
Iovance biotherapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)
SAN CARLOS, Calif., July 21, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, de...
July 21, 2023, 9:34 pm
Pfizer to end license deal with syros for blood disorder therapies
Syros Pharmaceuticals said on Friday Pfizer will terminate a license deal between the companies related to the development of ...
July 21, 2023, 5:46 pm
Recludix pharma enters into a strategic collaboration with sanofi to advance novel oral stat6 inhibitor in multiple immunological and inflammatory indications
– Recludix to receive $125 million in near-term payments and potentially more than $1.2 billion subject to future milestones, and up to double-digit...
July 20, 2023, 12:00 pm
Yunhong cti ltd. to host second quarter 2023 conference call on august 3rd
LAKE BARRINGTON, IL / ACCESSWIRE / July 20, 2023 / Yunhong CTI Ltd. (NASDAQ:CTIB) ("Yunhong CTI" or the "Company"), a leading manufacturer of custom f...
July 20, 2023, 9:00 am
Acumen announces pricing of upsized $130 million public offering
CHARLOTTESVILLE, Va. and CARMEL, Ind., July 18, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (“Acumen”) (NASDAQ: ABOS), a clinical-stage...
July 19, 2023, 2:31 am